BioSpace News Archive

Infinity Pharmaceuticals, Inc. will host a conference call on Wednesday, October 30, 2019 at 4:30 p.m. ET to review its third quarter 2019 financial results and provide an update on the company..

iCare Health Solutions, LLC has announced that its Diabetic Retinal Exam patient outreach program has helped five of its Florida-based Medicare Advantage partners earn the CMS Five-Star rating for their Healthcare Effectiveness Data and Information Set Diabetic Retinal Exam measure.

Soleno Therapeutics, Inc. (SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the pricing of an underwritten public offering of 11,166,667 shares of its common stock at a public offering price of $1.20 per share.

Today, 3D Systems (NYSE: DDD) and Antleron are announcing a collaboration, intended to play a pivotal role in advancing and accelerating breakthroughs in the biomedical industry.

The Blue Cross and Blue Shield of Minnesota Foundation has awarded more than $1.4M in grants to 12 nonprofits in Minnesota to support their efforts in helping people access health care coverage.

More Than 250 Dental Professionals Attended The Event To Learn The Latest Trends And Innovations In Dentistry From Leading Industry Experts

The Israeli start-up Laminate Medical Technologies, developer of the VasQ™ External Vascular Support Device for arteriovenous fistulas in patients requiring dialysis, today announces the completion of a capital raising following an investment from the London-based Valiance Asset Management, through its Luxembourg domiciled Life Sciences Global Investment Fund, in addition to the investment announced earlier this year.

Avera eCARE, the world’s leading telehealth provider, today announced that it has selected Tyto Care, creator of the healthcare industry’s first all-in-one modular device and telehealth platform for on-demand, remote medical exams, as an enterprise solution for virtual care.

Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and development of disease specific therapeutics, announced today that it was awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

Zyla Life Sciences (OTCQX: ZCOR) (“Zyla”), a commercial-stage life sciences company, today announced that Robert Radie, has resigned as president, chief executive officer and director of the Company to pursue other opportunities